Skip to main content
SpringerLink
Log in

Bedeutung der Inotropiemessungen in der Klinik

  • Chapter
Book cover Interventionen am Herzen

  • 31 Accesses

Zusammenfassung

Die klinisch-kardiologische Routine profitiert von möglichst vollständigen Einsichten in den Wirkungsmechanismus der Medikamente auf die Ventrikelfunktion. Der Nachweis von Änderungen der myokardialen Inotropie aber gerät oft nur fehlerhaft und unzuverlässig wegen des Aufwandes und der technischen Unzulänglichkeiten der damit verbundenen methodischen Bedingungen [75, 76]. An den folgenden 4 klinischen Untersuchungen kardiovaskulärer Interventionen soll die Bedeutung des Problems vorgestellt werden, nicht nur die konventionelle Hämodynamik mit ihren Änderungen, sondern auch die der Kontraktilität unter den Bedingungen der klinisch-diagnostischen Routine korrekt nachzuweisen. Anhand der Untersuchungsergebnisse soll eine praktikable Lösungsmöglichkeit für die Inotropiemessung unter klinischen Bedingungen erläutert werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alousi AA, Farah AE, Lesher CY, Opalka CJ (1979) Cardiotonic activity of amrinone WIN 40680, 5-amino-3,4’ bipyridine-6(1 H)-one. Circ Res 45: 666–677

    PubMed  CAS  Google Scholar 

  2. Amin DK, Schah PK, Hulse S, Shellock F (1985) Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL 17043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure. Am Heart J 109: 1006–1012

    Article  PubMed  CAS  Google Scholar 

  3. Aroney CN, Semigran MJ, Dec GW, Boucher CA, Fifer MA (1989) Inotropic effect of nicardipine in patients with heart failure: Assessment by left ventricular end-systolic pressure-volume analysis. J Am Coll Cardiol 14: 127–134

    Article  PubMed  CAS  Google Scholar 

  4. Axelrod RJ, DeMarco T, Dae M, Botvinick EH, Chatterjee K (1987) Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure. J Am Coll Cardiol 9: 1124–1130

    Article  PubMed  CAS  Google Scholar 

  5. Baan J, Van de Velde ET, DeBruin HG et al. (1984) Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70: 812–823

    Article  PubMed  CAS  Google Scholar 

  6. Bairn DS, McDowell AV, Cherniles J (1983) Evaluation of a new bipyridine inotropic agent — milrinone — in patients with severe congestive heart failure. N Engl J Med 309: 748–756

    Article  Google Scholar 

  7. Baker BJ, deSoyza N, Boyd CM, Murphy ML (1982) Effects of propafenone on left ventricular function. Circulation 66 (Suppl I): 11–67

    Google Scholar 

  8. Baker BJ, Dinh H, Kroskey D, de Soyza NDB, Murphy ML, Franciosa JA (1984) Effect of propafenone on left ventricular ejection fraction. Am J Cardiol 54: 20D–22D

    Article  PubMed  CAS  Google Scholar 

  9. Bailer D, Bretschneider HJ, Heilige G (1981) A critical look at currently used indirect indices of myocardial oxygen consumption. Basic Res Cardiol 76: 163–181

    Article  Google Scholar 

  10. Banim SO, DaSilva A, Stone D, Balcon R (1977) Observations of the hemodynamics of mexiletine. Postgrad Med J 53 (Suppl 1): 74

    PubMed  CAS  Google Scholar 

  11. В ashore TM, Walker S, Fossen DV, Fontana ME, Magorien RD (1985) Use of inferior vena caval occlusion to acutely alter preload in man. Circulation 72 (Suppl III): III–43

    Google Scholar 

  12. Benotti JR, Grossman W, Braunwald E et al. (1978) Hemodynamic assessment of amrinone: Anew inotropic agent. N Engl J Med 299:1373–1377

    Article  PubMed  CAS  Google Scholar 

  13. Bernard R, deHemptinne J, Gillet JM, Bernard M, Englert M (1978) Mexiletine in acute myocardial infarction-tolerance and hemodynamic effects. In: Sandoe E, Julian DG, Bell JW (eds) Management of ventricular tachycardia-Role of mexiletine. Proceedings of a symposium, Copenhagen. Excerpta medica, Amsterdam Oxford, p 324

    Google Scholar 

  14. Bertrand ME, Lablanche JM, Fourrier JL, Traisnel G, Mirsky I (1988) Left ventricular systolic and diastolic function during acute coronary balloon occlusion in humans. J Am Coll Cardiol 12: 341–347

    Article  PubMed  CAS  Google Scholar 

  15. Boltwood CM, Appleyard RF, Glantz SA (1989) Left ventricular volume measurement by conductance catheter in intact dogs. Parallel conductance volume depends on left ventricular size. Circulation 80: 1360–1377

    Article  PubMed  Google Scholar 

  16. Bowditch HP (1871) Über die Eigentümlichkeiten der Reizbarkeit, welche die Muskelfasern des Herzens zeigen. Sächs GesWiss 23: 652–689

    Google Scholar 

  17. Bowmann LK, Cleman MW, Cabin HC, Zaret BL, Jaffe CC (1988) Dynamics of early and late left ventricular filling determined by doppler two-dimensional echocardiography during percutaneous transluminal coronary angioplasty. Am J Cardiol 61: 541–545

    Article  Google Scholar 

  18. Bristow MR, Ginsberg R, Minobe W (1982) Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 397: 205–211

    Article  Google Scholar 

  19. Brown BG, Gundel WD, Gott VL, Covell JW (1974) Coronary collateral flowfollowing acute coronary occlusion: a diastolic phenomenon. Cardiovasc Res 8: 621–631

    Article  PubMed  CAS  Google Scholar 

  20. Burkhoff D, Van der Velde E, Kass D, Baan J, Maughan WL, Sagawa K (1985) Accuracy of volume measurement by conductance catheter in isolated, ejecting canine hearts. Circulation 72: 440–447

    Article  PubMed  CAS  Google Scholar 

  21. Burkhoff D, Sugiura S, Yue DT, Sagawa K (1987) Contractility-dependent curvilinearity of end-systolic pressure-volume relations. Am J Physiol 252H: 1218–1227

    Google Scholar 

  22. Buschmann G, Kühl UG, Varchmin G, Ziegler D (1988) Invitro and in-vivo bradycardic activities of KС 8857 (abstract). Naunyn-Schmiedebergs Arch Pharmacol 338 (Suppl): R49

    Google Scholar 

  23. Cameron J, Stafford W, Pritchard D, Norris R, Ravenscroft P (1984) Intravenous disopyramide in acute myocardial infarction: a haemodynamic and pharmacokinetic study. J Cardiovasc Pharm 6: 126–131

    Article  CAS  Google Scholar 

  24. Campbell NPS, Zaidi SA, Adgey AA, Patterson GC, Pantridge JF (1979) Observations on hemodynamic effects of mexiletine. Br Heart J 41: 182

    Article  PubMed  CAS  Google Scholar 

  25. Chilson DA, Zipes DP, Heger JJ (1982) Propafenone, clinical and electrophysiological effects in patients with ventricular tachycardia. Clin Res 30: 706A

    Google Scholar 

  26. Cody RJ, Kubo SH, Covit AB (1984) Regional blood flow and neurohumoral response to chronic milrinone in CHF. Circulation 70:11–192

    Google Scholar 

  27. Crawford MH, Richards KL, Sodums MT, Kennedy GT (1984) Positive inotropic and vasodilator effects of MDL 17043 in patients with reduced left ventricular performance. Am J Cardiol 53: 1051–1053

    Article  PubMed  CAS  Google Scholar 

  28. Crottogini AJ, Wilishaw P, Barra JG, Armientano R, Fischer EIC, Pichel RH (1987) Inconsistency of the slope and the volume intercept of the end-systolic pressure-volume relationships as individual indexes of inotropic state in conscious dogs: presentation of an index combining both variables. Circulation 76: 1115–1126

    Article  PubMed  CAS  Google Scholar 

  29. Dammgen JW, Lamping KA, Gross GJ (1985) Actions of two new bradycardie agents, AQ-AH208 and UL-FS 49, on ischemic myocardial perfusion and function. J Cardiovasc Pharmacol 7: 71–79

    Article  PubMed  CAS  Google Scholar 

  30. DePaola AAV, Horowitz LN, Morganroth J et al. (1987) Influence of left ventricular dysfunction on flecainide therapy. J Am Coll Cardiol 9: 163–168

    Article  CAS  Google Scholar 

  31. DiBianco R, Gottdiener JS, Singh SN, Fletcher RD (1987) A review of the effects of disopyramide phosphate on left ventricular function and the peripheral circulation. Angiology 38: 174–183

    CAS  Google Scholar 

  32. Duchosal F, Opie LH (1987) KС 8857, a new compound with combined bradycardic and positive inotropic effects (abstracts). J Mol Cell Cardiol 19 (Suppl III): 19

    Article  Google Scholar 

  33. Dukes ID, Morad M (1989) Tedisamil inactivates transient outward K+ current in rat ventricular myocytes. Am J Physiol 257: H1746–H1749

    PubMed  CAS  Google Scholar 

  34. Dukes ID, Morad M (1989) Tedisamil modulates outward K+channels in rat and guinea pig ventricular myocytes (abstract). Circulation 80 (Suppl II): 517

    Google Scholar 

  35. Falsetti HL, Mates RE, Greene DG (1971) Vmax as an index of contractile state in man. Circulation 43: 467–479

    PubMed  CAS  Google Scholar 

  36. Grbic M, Sigwart U (1990) Left ventricular filling during acute ischemia. In: Serruys PW, Simon R, Beatt KJ (eds) PTCA, an investigational tool and a non-operative treatment of acute ischemia vol 1. Kluwer, Lancaster (Developments in Cardiovascular Medicine, pp 167–174)

    Chapter  Google Scholar 

  37. Grohs JG, Fischer G, Raberger G (1988) Cardiac and hemodynamic effects of the selective bradycardic agent KС 8857 during exercise-induced myocardial ischemia. Eur J Pharmacol 161: 53–60

    Article  Google Scholar 

  38. Grossman W (ed) (1980) Cardiac catheterization and angiography. Lea & Febiger, Philadelphia, pp 87–131, 213–283

    Google Scholar 

  39. Gülker H, Thale J, Olbing B, Heuer H, Frenking B, Bender F (1985) Assessment of the antiarrhythmic profile of the antiarrhythmic profile of the new class I agent diprafenone. Arzneimittelforschung 35 (Suppl II): 1387

    PubMed  Google Scholar 

  40. Halpern M, Sigwart U (1990) Does Diltiazem protect the ischemic myocardium during PTCA? In: Serruys PW, Simon R, Beatt KJ (eds) PTCA, an investigational tool and a non-operative treatment of acute ischemia vol 101. Kluwer, Lancaster (Developments in Cardiovascular Medicine, pp 283–304)

    Chapter  Google Scholar 

  41. Herman HJ, Singh R, Damman JF (1969) Evaluation of myocardial contractility in man. Amer Heart J 77: 755–766

    Article  Google Scholar 

  42. Hermann HC, Ruddy TD, Dec W, Strauss HW, Boucher CA (1987) Inotropic effect of enoximone in patients with severe heart failure: Demonstration by left ventricular endsystolic pressure-volume analysis. J Am Coll Cardiol 9: 1117–1123

    Article  Google Scholar 

  43. Hermiller JB, Leithe ME, Magorien RD et al. (1984) Amrinone insevere congestive heart failure: Another look at an intriguing new cardioactive drug. J Pharm Exp Ther 228: 319–326

    CAS  Google Scholar 

  44. Higgins CB, Vatner SF, Franklin D, Braunwald E (1973) Extent of regulation of heart’s contractile state in conscious dogs by alteration in frequency of contraction. J Clin Invest 52: 1187–1194

    Article  PubMed  CAS  Google Scholar 

  45. Howard PG, Abraham S, Courtice ID, Walker MJA (1989) Further studies into the ECG effects of tedisamil (KС 8857) in rats (abstract). Proc West Pharm Soc 32: 183

    CAS  Google Scholar 

  46. Jaski BE, Fifer MA, Wright RF et al. (1985) Positive inotropicand vasodilator actions of milrinone in patients with sereve congestive heart failure. J Clin Invest 75: 643–649

    Article  PubMed  CAS  Google Scholar 

  47. Josephson MA, Ikeda N, Singh BN (1984) Effects of flecainide on ventricular function: Clinical and experimental correlations. Am J Cardiol 53: 95B–100B

    Article  PubMed  CAS  Google Scholar 

  48. Kass DA, Yamazaki T, Burckhoff D, Maughan WL, Sagawa K (1986) Determination of left ventricular endsystolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation 73: 586–595

    Article  PubMed  CAS  Google Scholar 

  49. Kass DA, Maughan WL (1988) From “Emax” to pressure-volume relations: a broader view. Circulation 77: 1203–1212

    Article  PubMed  CAS  Google Scholar 

  50. Kass DA, Midei M, Brinker J, Maugham WL (1990) Influence of coronary occlusion during PTCA on end-systolic and end-diastolic pressure-volume relations in humans. Circulation 81: 447–460

    Article  PubMed  CAS  Google Scholar 

  51. Kass DA (1992) Clinical evaluation of left heart function by conductance catheter technique. Eur Heart J 13 (Suppl E): 57–64

    PubMed  Google Scholar 

  52. Kereiakes D, Chatterjee K, Parmley WW et al. (1984) Intravenous and oral MDL 17043 (a new inotropic-vasodilatoragent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients. Am J Coll Cardiol 4: 884–889

    Article  CAS  Google Scholar 

  53. Kleinsorge H, Straubing S (1960) Vergleichende Untersuchungen der inotropen Herzwirkung von Ajmalin und Procainamid. Klin Wochenschr 38: 290–298

    Article  PubMed  CAS  Google Scholar 

  54. Kurz R (1984) Medizinische Meßtechnik und Biosignalverarbeitung in der kardiologischen Diagnostik. Grundlagen und Anwendung. In: Kindler M (Hrsg) Reihe Biomedizinische Technik Bd 1. Schmitz, Giessen

    Google Scholar 

  55. Kobinger W (1985) Specific bradycardic agents, a new approach to therapy in angina pectoris. Prog Pharmakol 54: 89–100

    Google Scholar 

  56. Labovitz AJ, Lewen MK, Kern DM, Vandormael M, Deligonal U, Kennedy HL (1987) Evaluation of left ventricular systolic and diastolic dysfunction during transient myocardial ischemia produced by angioplasty. J Am Coll Cardiol 10: 748–755

    Article  PubMed  CAS  Google Scholar 

  57. Leatherman GF, Shook TL, Leatherman SM, Colucci WS (1989) Use of a conductance catheter to detect increased left ventricular inotropic state by end-systolic pressure -Volume analysis. Basic Res Cardiol 84 (Suppl 1): 247–256

    Article  PubMed  Google Scholar 

  58. Legrand V, Vandormael M, Collignon P, Kulbertus HE (1983) Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease. Am J Cardiol 51: 422–426

    Article  PubMed  CAS  Google Scholar 

  59. Ludmer PL, Wright RF, Arnold MO et al. (1986) Separation of the direct myocardial and vasodilator actions and milrinone administered by an intracoronary infusion technique. Circulation 73: 130–137

    Article  PubMed  CAS  Google Scholar 

  60. Mason DT (1969) Usefulness and limitations of the rate of rise of intraventricular pressure (dP/dt) in the evaluation of myocardial contractility in man. Am J Cardiol 23: 516–527

    Article  PubMed  CAS  Google Scholar 

  61. Mathur PP (1972) Cardiovasc effects of a new antiarrhythmic agent, disopyramide phosphate. Am Heart J 84: 764–770

    Article  PubMed  CAS  Google Scholar 

  62. McKay RG, Miller MJ, Ferguson JJ, Momomura SL, Shahagian B, Grossman W, Pasternak RC (1986) Assessment of left ventricular end-systolic pressure-volume relations with an impedance catheter and transient inferior vena cava occlusion: Use of this system in the evaluation of the cardiotonic effects of dobutamine, milrinone. Am J Coll Cardiol 8: 1152–1160

    Article  CAS  Google Scholar 

  63. Merx W (1981) Mexiletin beim akuten Myokardinfarkt. In: Lüderitz В (Hrsg) Ventrikuläre Herzrhythmusstörungen, Pathophysiologie, Klinik, Therapie. Springer, Berlin Heidelberg New York, S 263–267

    Google Scholar 

  64. Mirsky I, Tajimi T, Peterson KL (1987) The development of the entire end-systolic pressure-volume and ejection fraction-afterload relation: a new concept of systolic myocardial stiffness. Circulation 76: 343–356

    Article  PubMed  CAS  Google Scholar 

  65. Mitrovic V, Oehm E, Liebrich A, Thormann J, Schlepper M (1992) Hemodynamic and antiischemic effects of tedisamil in humans. Cardiovasc Drugs Ther 6: 353–360

    Article  Google Scholar 

  66. Mulierei LA, Leavitt BJ, Hasenfuss G, Allen PD, Alpert NR (1992) Contraction frequency dependence of twitch and diastolic tension in human dilated cardiomyopathy (tension-frequency relation in cardiomyopathy). Basic Res Cardiol 87 (Suppl 1): 199–212

    Google Scholar 

  67. O’Brien P, Drage D, Kooroush S, Brooks HL, Wartier DC (1992) Regional distribution of myocardial perfusion by UL-FS49, a selective bradycardic agent. Am Heart J 123: 566–574

    Article  PubMed  Google Scholar 

  68. Oexle B, Weirich J, Antoni H (1987) Electrophysiological profile of KС 8857, a new bradycardic agent (abstract). J Mol Cell Cardiol 19 (Suppl III): 65

    Article  Google Scholar 

  69. Petein M, Levine TC, Cohn JN (1984) Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure. J Am Coll Cardiol 4: 364–371

    Article  PubMed  CAS  Google Scholar 

  70. Pieske B, Hasenfuss G, Holubarsch Ch, Schwinger R, Böhm M, Just H (1992) Alterations of the force-frequency relationship in the failing human heart depend on the underlying cardiac disease. Basic Res Cardiol 87 (Suppl 1): 213–221

    PubMed  Google Scholar 

  71. Podrid PJ, Schoeneberger A, Lown B (1980) Congestive heart failure caused by oral disopyramide. N Engl J Med 302: 614–617

    Article  PubMed  CAS  Google Scholar 

  72. Quinones MA, Gaasch WH, Alexander JK (1976) Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumetric indices of myocardial contractility in man. Circulation 53: 293–302

    PubMed  CAS  Google Scholar 

  73. Reiffen M, Eberlein W, Mueller P et al. (1990) Specific bradycardic agents I. Chemistry, pharmacology, and structure activity relationships of substituted benzazepinones, a new class of compounds exerting antiischemic properties. J Med Chem 33: 1496–1507

    Article  PubMed  CAS  Google Scholar 

  74. Ruskin JN (1989) The cardiac arrhythmia suppression trial (CAST); Special report: Effect of encainide and flecainide om mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321: 386–388, 406–412

    Article  PubMed  CAS  Google Scholar 

  75. Sagawa K (1984) Endsystolic pressure-volume relationship in retrospect and prospect. Fed Proc 43: 2399–2409

    PubMed  CAS  Google Scholar 

  76. Sagawa K (1978) The ventricular pressure-volume diagram revisited. Circ Res 43: 677–6874

    PubMed  CAS  Google Scholar 

  77. Salerno DM, Granrud G, Sharkey P, Asinger R, Hodges M (1984) A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes. Am J Cardiol 53: 77–83

    Article  PubMed  CAS  Google Scholar 

  78. Saunamäki KI (1975) Hemodynamic effects of a new antiarrhythmic agent, mexiletine (Kö1173) in ischemic heart disease. Cardiovasc Res 9: 788

    Article  PubMed  Google Scholar 

  79. Schaper W (ed) (1979) Determinants of myocardial oxygen consumption and coronary blood flow. In: The pathophysiology of myocardial perfusion. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 173–176

    Google Scholar 

  80. Schlepper M, Neuss H (1983) Effects of propafenone on hemodynamics and cardiac inotropy. In: Schlepper M, Olsson B (eds) Cardiac arrhythmias, diagnosis, prognosis, therapy. Proceedings, First International Rytmonorm-Congress. Springer, New York, pp 133–139

    Google Scholar 

  81. Schlepper M, Thormann J, Mitrovic V (1989) Cardiovascular effects of forscolin and phosphodiesterase-III inhibitors. Basic Res Cardiol 84 (Suppl 1): 197–222

    Article  PubMed  Google Scholar 

  82. Schmitt H, Schmitt I (1960) Sur a pharmacologie de l’ajmaline. Arch Int Pharmacodyn 127: 163–166

    CAS  Google Scholar 

  83. Serruys PW, Wijns W, van den Brand M et al. (1984) Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty. Circulation 70: 25–36

    Article  PubMed  CAS  Google Scholar 

  84. Sigwart U, Grbic M, Essinger A, Fischer A, Morin D, Sadeghi H (1982) Myocardial function in man during acute coronary balloon occlusion. Circulation 66 (Suppl II): 86

    Google Scholar 

  85. Spratt JA, Tyson GS, Glower DD, David JW, Muhlbaier LH, Olsen CO, Rankin JS (1987) The end-systolic pressure-volume relationship in conscious dogs. Circulation 75: 1295–1302

    Article  PubMed  CAS  Google Scholar 

  86. Strain J, Grose R, Maskin CS, LeJemtel TH (1985) Effects of a new cardiotonic agent, MDL 17043 on myocardial contractility and left ventricular performance in congestive heart failure. Am Heart J 110: 91–96

    Article  PubMed  CAS  Google Scholar 

  87. Suga H, Sagawa K (1974) Instantaneous pressure volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res 35: 117–123

    PubMed  CAS  Google Scholar 

  88. Thompson DS, Juul SM, Wilmshurst P (1981) Effects of sodium nitroprusside upon cardiac work, efficiency and substrate extraction in severe left ventricular failure. Br Heart J 46: 394–400

    Article  PubMed  CAS  Google Scholar 

  89. Thormann J, Kramer W, Kindler M, Neuss H, Schlepper M (1985) Linksventrikuläre Funktionsdiagnostik mit Analyse serieller Druck-Volumen-Beziehungen: Erster Einsatz der Conductance-(Volumen-)Kathetertechnik. Z Kardiol 74 (Suppl 5) 5: 124

    Google Scholar 

  90. Thormann J, Kramer W, Kindler M, Kremer P, Schlepper M (1987) Bestimmung der Wirkkomponenten von Amrinon durch kontinuierliche Analyse der Druck-Volumen-Beziehung; Anwendung der Conductance-(Volumen-) Kathetertechnik und der schnellen Laständerung durch Ballonokklusion der Vena cava inferior. Z Kardiol 76: 530–540

    PubMed  CAS  Google Scholar 

  91. Thormann J, Kremer P, Mitrovic V, Neuzner J, Bahawar H, Schlepper M (1989) Effects of enoximone in coronary artery disease: Increased pump function, improved ventricular wall motion, and abolition of pacing-induced myocardial ischemia. J Appl Cardiol 4: 31–45

    Google Scholar 

  92. Thormann J, Kramer W, Kremer P, Schlepper M (1989) Influence of the new class I antiarrhythmic agent diprafenone on the endsystolic pressure-volume relationship (conductance technique). Cardiovasc Drugs Ther 3: 145–154

    Article  PubMed  CAS  Google Scholar 

  93. Thormann J, Hüting P, Kremer P, Mitrovic V, Wissemann J, Bahawar H, Schlepper M (1990) Einfluß des Klasse-IA-Antiarrhythmikums Ajmalin auf die end-systolische Druck-Volumen-Beziehung (Conductance-Technik). Z Kardiol 79: 706–716

    PubMed  CAS  Google Scholar 

  94. Thormann J, Hüting J, Kremer P, Wissemann J, Mitrovic V, Dietrich HA, Schlepper M (1990) Enoximone: True inotropic effects? Do they cause ischemia? Analysis of endsystolic pressure-volume relations using the conductance(volume) catheter technique. Cardiovasc Drugs Ther 4: 1403–1416

    Article  PubMed  CAS  Google Scholar 

  95. Thormann J (1991) Kardiodepression durch Klasse-1-Antiarrhythmika? Nachweis der hämodynamisch wirksamen Komponenten. Herz/Kreisl 23: 305–311

    Google Scholar 

  96. Thormann J, Liebrich A, Mitrovic V, Strasser R, Dieterich HA, Schlepper M (1992) Proof for piroximone’s inotropic influence; can it safely be used in coronary artery disease? Analysis of end-systolic pressure-volume relations (conductance technique). J Cardiovasc Pharmacol 20: 50–62

    PubMed  CAS  Google Scholar 

  97. Thormann J, Kremer P, Strasser R, Wissemann J, Bahavar H, Schlepper M (1992) Auswirkungen PTCA-induzierter Ischämie auf Hämodynamik und die Druck-Volumen-Beziehung; Conductance-(Volumen-)Kathetertechnik. Herz/Kreisl 24: 119–126

    Google Scholar 

  98. Thormann J (1992) The influence on clinical intervention on pressure-volume relationships — the conductance (volume) technique. Eur Heart J 13 (Suppl E): 69–79

    PubMed  Google Scholar 

  99. Thormann J, Mitrovic V, Strasser R, Pitschner HF, Riedel H, Bahavar H, Schlepper M (1993) Wird die bradykardi-sierende Wirkung von Tedisamil mit Inotropie-Einbuße erkauft? Eine Druck-Volumen-Analyse mit der Conductance-(Volumen-)Kathetertechnik bei Patienten mit koronarer Gefäßkrankheit. Z Kardiol 82: 211–221

    PubMed  CAS  Google Scholar 

  100. Thormann J (1993) Clinical aspects of drugs affecting contractile proteins and myosin Ca2+ sensitivity of the ß-stimulator denopamine (TA-064), and of the recent phosphodiesterase inhibitor drugs amrinone, enoximone, and piroximone. In: Gwathmey JK, Briggs GM, Allen PD (eds) Heart failure, basic science and clinical aspects, chapt 23. Dekker, New York HongKong, pp 475–518

    Google Scholar 

  101. Uretzky BF, Generalovich T, Reddy PS et al. (1983) The acute hemodynamic effects of a new agent, MDL 17043, in the treatment of congestive heart failure. Circulation 67: 823–828

    Article  Google Scholar 

  102. Van Fossen D, Fontana ME, Unverferth DV, Walker S, Kolibash AJ, Bashore TM (1987) Safety and efficacy of inferior vena caval occlusion to rapidly alter ventricular loading conditions in idiopathic dilated cardiomyopathy. Am J Cardiol 59: 937–942

    Article  PubMed  Google Scholar 

  103. Velebit V, Podrid P, Lown B (1982) Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 65: 886–894

    Article  PubMed  CAS  Google Scholar 

  104. Weber KT, Janicki JS (1979) The metabolic demand and oxygen supply of the heart. Physiologic and clinical considerations. Am J Cardiol 44: 722–729

    Article  PubMed  CAS  Google Scholar 

  105. Wester HA, Mouselimis N (1982) Einfluß von Antiarrhythmika auf die Myokardfunktion. Dtsch Med Wochenschr 107: 1262–1266

    Article  PubMed  CAS  Google Scholar 

  106. Wijns W, Serruys PW, Slager CJ, Grimm J, Krayenbuehl HP, Hugenholtz PG, Hess OM (1986) Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure-radius relations. J Am Coll Cardiol 7: 455–463

    Article  PubMed  CAS  Google Scholar 

  107. Wilmshurst PT, Thompson DS, Jenkins BS et al. (1983) Hemodynamic effects of intravenous amrinone in patients with impaired left ventricular function. Br Heart J 49: 77–82

    Article  PubMed  CAS  Google Scholar 

  108. Wilmshurst PT, Thompson DS, Suhl SM et al. (1983) Comparison of the effects of amrinone and sodium nitroprusside on hemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy. Br Heart J 52: 38–48

    Article  Google Scholar 

  109. Wiske PS, Palacios I, Block PC, O’Gara P, Strauss HW, Okada RD, Boucher CA (1986) Assessment of regional myocardial perfusion with thallium imaging during transient left anterior descending coronary arterial occlusion during angioplasty. Am J Cardiol 57: 1083–1087

    Article  PubMed  CAS  Google Scholar 

  110. Yang SS, Bentivoglio LG, Maranhao V, Goldberg H (1978) From cardiac catheterization data to hemodynamic parameters, 2nd ed. Davis, Philadelphia Pennsylvania, pp 280–297

    Google Scholar 

Download references

Authors
  1. J. Thormann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Herzchirurgie Salzburg, Müllner Hauptstraße 48, A-5020, Salzburg, Österreich

    Felix Unger

  2. Medizinische Klinik, Diakonissenkrankenhaus Mannheim, Akademisches Lehrkrankenhaus der Universität Heidelberg, Speyerer Straße 91-93, D-68163, Mannheim, Deutschland

    Hubert Mörl

  3. Fachpharmakologe DGPT, Am Huhlchen 5, D-55130, Mainz, Deutschland

    Hans Armin Dieterich

  4. School of Medicine, Dpts. of Medicine and Pharmacology, Georgetown University, Washington D.C., USA

    Hans Armin Dieterich

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Thormann, J. (1995). Bedeutung der Inotropiemessungen in der Klinik. In: Unger, F., Mörl, H., Dieterich, H.A. (eds) Interventionen am Herzen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93558-9_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93558-9_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-93559-6

  • Online ISBN: 978-3-642-93558-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation